Alexion Employees Volunteer Together to Enhance Their Local Communities during Second Annual Global Day of Service
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced that more than 1,300 employees are rallying together in support of community service initiatives focused on health, wellness, and education as part of the Company’s second annual Global Day of Service. Alexion has partnered with non-profit organizations in nearly 30 of the Company’s local communities across North America, Europe, Latin America, Asia, and Australia to coordinate service projects that will have a positive impact on neighborhoods and people in need. Volunteers will beautify facilities, hold educational and training workshops, prepare meals and care packages, and much more.
“At Alexion, we are committed to enriching the communities where we live and work as we pursue our mission of developing and delivering life-changing therapies for patients with rare diseases,” said Ludwig Hantson, Chief Executive Officer of Alexion. “We are excited to build on the success and momentum of last year’s inaugural Global Day of Service with our second annual event that supports our company values and tackles some of the most pressing needs in our local neighborhoods.”
In 2016, Alexion employees provided more than 7,500 service hours to communities around the world during its first Global Day of Service. Activities included beautifying local schools, parks, and homeless shelters; preparing meals for families and individuals facing an illness; and leading activities for adults and children with special needs.
Alexion’s second annual Global Day of Service activities include:
- New Haven, CT: Transforming the Celentano Biotech, Health, and Medical Magnet School and Wallingford Emergency Shelter, a program of Columbus House, by building new furniture, painting murals, landscaping, and more. Volunteers will also pack meals for Rise Against Hunger and assemble kits for people spending their first night at a homeless shelter.
- Boston, MA: Volunteering at the Community Academy of Science and Health, where employees will coach students on career development, paint murals, and assemble furniture.
- Holden, MA: Working with the Be Like Brit Foundation, an organization dedicated to serving the children of Haiti, to organize and package items to be sent to an orphanage in Haiti.
- Smithfield, RI: Returning to Mary E. Fogarty Elementary School to beautify the interior and exterior of the school as well as coordinate a science, technology, engineering, and math (STEM) fair.
- Bogart, GA: Partnering with Extra Special People to work at a camp for children with developmental disabilities.
- Washington, DC: Partnering with Martha’s Table at the Joyful Food Market, a monthly community event designed to reduce hunger and increase access to fresh fruits and vegetables.
- Mexico City, Mexico: Waterproofing the roof of DAYA, a foster home that supports at-risk adolescent girls, and playing volleyball and planting a vegetable garden with the residents.
- Vaughan, Canada: Volunteering at the Yellow Brick House, a non-profit organization that offers shelter, counseling, and other services to women and children who are impacted by domestic violence.
- Zurich, Switzerland: Participating in a variety of activities including visiting the Zurich Zoo with children suffering from rare diseases in partnership with the Foundation for People with Rare Diseases (KMSK); playing bingo with the inhabitants of two retirement centers in Zurich (Alterszentrum Herzogenmühle and Sydefädeli); and partnering with Foundation St. Jakob to work with people with impairments in a local bakery and packaging facility.
- London, UK: Participating in a beautification project at Sweet Tree Farming for All, a facility for children and young adults with a variety of care and support needs.
- Birmingham, UK: Participating in arts and crafts and Christmas present wrapping at Birmingham Children’s Hospital.
- Dublin, Ireland: Painting at Coolmine Therapeutic Centre, a rehabilitation center.
- Athlone, Ireland: Helping to transform the Midlands Simon Community homeless emergency accommodation.
- Madrid, Spain: Partnering with Grupo AMAS, an organization that supports and promotes the rights of people with intellectual disabilities, to participate in an improvisation workshop called Theater for Inclusion.
- Barcelona, Spain: Teaming up with Fundacio Finestrelles, an organization that supports individuals with intellectual disabilities, to improve the grounds and hold educational workshops.
- Belgium and The Netherlands: Maintaining indoor and outdoor facilities at Kampenhoeve de STER, an animal therapy center that serves children and adults with physical and developmental disabilities.
- Milan, Italy: Planting ginkgo biloba trees at a local park.
- Rome, Italy: Cleaning up a local park, maintaining benches, and planting.
- Munich, Germany: Participating in a variety of local volunteer projects, including furnishing and decorating schools, preparing and distributing meals, providing science and health education workshops, and assisting in a repair shop run by disabled individuals.
- Prague, Czech Republic: Partnering with the Hospital of the Sisters of Mercy of St. Charles Borromeo to prepare Christmas cakes that will be sold during fundraising events for the hospital.
- Dubai, United Arab Emirates: Partnering with Dar al Ber Society, a humanitarian network, to collect food and other items for people in need.
- Shanghai, China: Participating in a charity run to raise funds to provide meals for students in rural and impoverished areas.
- Tokyo, Japan: Teaming up with Arakawa Clean Fund to take part in a river clean-up project; gardening and arranging a petting zoo for children at Keifuku Ikujikai Azabus Infants' Home; and hosting an after-school cooking class for local children with disabilities at the School Center Himawari Batake.
- Mumbai, India: Hosting a fun and educational event for children from underserved communities.
- Istanbul, Turkey: Hosting cooking and art workshops for Dusler Akademisi, an organization that provides cultural and artistic training free of charge for disabled and socially disadvantaged youth.
- Sao Paulo, Brazil: Painting and repairing a health center.
- Bogota, Colombia: Participating in beautification projects that include painting and cleaning at Pasquilla School, an under-served local school.
- Buenos Aires, Argentina: Providing support to Hogar Cura Brochero, an organization that offers services and asylum for the homeless.
- Frenchs Forest, Australia: Joining OzHarvest’s “Cooking for a Cause” cooking class to transform rescued food into restaurant-quality meals that are then delivered to local communities in need.
Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare disorders. Alexion is the global leader in complement inhibition and has developed and commercializes the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG). In addition, Alexion has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D). As the leader in complement biology for over 20 years, Alexion focuses its research efforts on novel molecules and targets in the complement cascade, and its development efforts on the core therapeutic areas of hematology, nephrology, neurology, and metabolic disorders. This press release and further information about Alexion can be found at: www.alexion.com.
Alexion Pharmaceuticals, Inc.
Kim Diamond, 475-230-3775
Executive Director, Corporate Communications
Mandy Fahey, 475-230-3778
Director, Corporate Communications
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
A Better Way to Earn Interest on Digital Assets18.1.2019 01:00 | Pressemelding
Cred, the leading provider of crypto borrowing and lending with over $300 million in credit facilities, today announced the launch of CredEarn* on the Uphold platform. CredEarn allows Uphold customers to lend their crypto and fiat assets to Cred and receive up to 10% of annualized interest. “We’re thrilled to offer consumers the opportunity to earn interest on their digital assets and fiat currencies,” said Dan Schatt, Co-founder and President of Cred. “In a bear market, customers can benefit from the liquidity they receive when obtaining a fixed amount of interest in USD or Stablecoin. In a bull market, customers also benefit by receiving the full upside on the amount of crypto they originally committed.” CredEarn customers can commit to a six-month term with the ability to rollover assets for additional periods. No account minimum is needed and interest is paid out in U.S. Dollars or Stablecoin every three months on Uphold. The principal is paid back in the fiat or crypto amounts tha
Servier and Taiho Oncology Present Latest LONSURF® (trifluridine/tipiracil) Data at ASCO 2019 Gastrointestinal Cancers Symposium (ASCO GI)17.1.2019 23:45 | Pressemelding
Servier and Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), jointly announced today that the safety and efficacy data in the gastrectomy patient subgroup of the global Phase III trial TAGS evaluating LONSURF® (trifluridine/tipiracil, TAS-102) in patients with metastatic gastric cancer (mGC) are consistent with the overall study results published in The Lancet Oncology. These data were highlighted in an oral presentation at the ASCO 2019 Gastrointestinal Cancers Symposium (ASCO-GI) on Thursday 17 January. In TAGS, 221 (44%) of the 507 randomized mGC patients had undergone prior gastrectomy (147 LONSURF, 74 placebo), which is reflective of the real-world patient population diagnosed with mGC. The results confirmed that trifluridine/tipiracil prolonged survival versus placebo regardless of prior gastrectomy. The overall results of TAGS demonstrated that patients treated with oral trifluridine/tipiracil showed a clinically meaningful and statistically s
ISACA Announces 2019 Slate of Events for Business Technology Professionals Around the Globe During its 50th Anniversary Year17.1.2019 19:24 | Pressemelding
ISACA, a global association serving technology audit, assurance, governance and cybersecurity professionals, celebrating its 50th anniversary in 2019, announced its annual event schedule, which includes learning opportunities focused on emerging technologies, innovation, best practices and professional development. Disruptive technologies over the last 50 years and in the future of business enterprise, and the evolution of technology careers and ISACA professions, will be featured in conjunction with the ISACA anniversary year at nearly every venue. ISACA’s growing Cybersecurity Solution Portfolio, including the CSX Training Platform and the CMMI Cybermaturity Platform, will be highlighted in new conferences in 2019, which will include events in North America and Europe. The 2019 CACS conferences, set for North America, Europe, Asia, Africa, the Oceania region and Latin America, will offer educational sessions in audit and assurance, big data, risk management, governance and more. All
HighLife Closes a €32 Million Round B Financing17.1.2019 17:25 | Pressemelding
HighLife SAS, a medtech company focused on the development of a unique transcatheter mitral valve replacement (“TMVR”) system to treat patients suffering from mitral regurgitation, announced today it had closed a €32 million round of equity financing. Proceeds from the financing will be used to complete the development of the company’s transcatheter transseptal mitral valve implantation program, which includes regulatory approval trials in Europe to obtain the CE mark and a first clinical trial in the U.S. via an Early Feasibility Study (EFS). The Series B round was co-led by U.S. Venture Partners (“USVP”) and Andera Partners, with Sectoral Asset Management and Jose Calle Gordo, Chairman of the company, joining the round. Sofinnova Partners, which led the Series A round, continues to support the company and participated in this latest round of financing. Bryan Garnier & Co (Paris) acted as private placement agent for this financing. “I am very pleased to announce the closing of the Ser
The Brightline™ Initiative, led by Project Management Institute, to Support The Economist Davos Panel17.1.2019 15:00 | Pressemelding
The Brightline™ Initiative, a coalition dedicated to helping executives bridge the gap between strategy design and delivery, along with Project Management Institute is hosting The Economist Events panel discussion entitled “Humans 2.0: Designing and Implementing a Future Proof Strategy.” In line with Davos’ overarching theme, “Globalization 4.0: Shaping a Global Architecture in the Age of the Fourth Industrial Revolution,” panelists will discuss how business leaders can harness the power of people to adapt and implement corporate strategies and grapple with the effects of disruptive technologies. This topic is of particular interest to PMI, the leading member of Brightline, given how this wave of disruption calls for organizations to rely on successful implementation of new strategies at unprecedented scope and speed to meet market demands. “As a coalition committed to moving from idea to strategy implementation to results, we’re delighted to partner with The Economist Events to bring
MSCI Schedules Investor Conference Call to Review Fourth Quarter and Full Year 2018 Results17.1.2019 14:00 | Pressemelding
MSCI Inc. (NYSE:MSCI), a leading provider of indexes and portfolio construction and risk management tools and services for global investors, today announced it will release its results for the fourth quarter and full year 2018 on Thursday, January 31, 2019. MSCI's senior management will review the fourth quarter and full year 2018 results on Thursday, January 31, 2019 at 11:00 AM Eastern Time. To listen to the live event, visit the events and presentations section of MSCI's Investor Relations homepage, http://ir.msci.com/events.cfm, or dial 1-877-376-9931 conference ID: 3474708 within the United States. International callers dial 1-720-405-2251 conference ID: 3474708. The earnings release and related investor presentation used during the conference call will be made available on MSCI's Investor Relations homepage. An audio recording of the conference call will be available on our Investor Relations website, http://ir.msci.com/events.cfm, beginning approximately two hours after the conc